(Funded by the National Institutes of Health)
Researchers from Cedars-Sinai Cancer; Caltech; California State University, Northridge; and Technion-Israel Institute in Haifa, Israel, have designed nanobioparticles that can cross the protective blood–brain barrier and deliver therapy directly into cancerous tumor cells. The findings could help clinicians target brain tumors previously unreachable by chemotherapy. The investigators conducted experiments using a unique blood-brain barrier “organ chip.” When investigators flowed the nanobioparticles through the blood vessel portion of the chip, they saw that it crossed over and accumulated in the brain matter.

(Funded by the National Institutes of Health)
Researchers at the University of Pennsylvania have demonstrated that ferumoxytol, an U.S. Food and Drug Administration-approved iron oxide nanoparticle formulation, greatly reduces infection in patients diagnosed with apical periodontitis. The researchers showed that topical applications of ferumoxytol in combination with hydrogen peroxide potently disrupt biofilms – dense, sticky communities of bacteria that attach to surfaces and cause infections. The researchers treated 44 patients with periapical periodontitis and found that patients who received ferumoxytol/hydrogen peroxide achieved a 99.9% reduction in bacterial counts without experiencing any adverse effects.

(Funded by the U.S. National Science Foundation and the National Institutes of Health)
Using the nanostructures and microstructures found on Morpho butterfly wings, scientists at the University of California San Diego have developed a simple and inexpensive way to analyze cancerous tissues. Fibrosis, the accumulation of fibrous tissue, is a key feature of many diseases, including cancer, and evaluating the extent of fibrosis in a biopsy sample can help determine whether a patient’s cancer is in an early or advanced stage. The researchers discovered that by placing a biopsy sample on top of a Morpho butterfly wing and viewing it under a standard microscope, they can assess whether a tumor’s structure indicates early- or late-stage cancer – without the need for stains or costly imaging machines.

(Funded by the National Institutes of Health)
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system that can deliver messenger RNA (mRNA) to the brain via intravenous injection – a challenge that has long been limited by the protective nature of the blood-brain barrier. The system takes advantage of natural transport mechanisms within the blood-brain barrier that move nanoparticles across the blood-brain barrier. The findings, in mouse models and isolated human brain tissue, show the potential of this system for future treatments for Alzheimer’s disease, amyotrophic lateral sclerosis, brain cancer, and drug addiction.

(Funded by the U.S. Department of Agriculture and the National Institutes of Health)
Researchers from Rutgers University, the New Jersey Institute of Technology, the Connecticut Agricultural Experiment Station in New Haven, CT, and the Environmental and Occupational Health Sciences Institute in Piscataway, NJ, have shown that microplastic and nanosplastic particles in soil and water can significantly increase how much toxic chemicals plants and human intestinal cells absorb. Using a cellular model of the human small intestine, the researchers found that nano-size plastic particles increased the absorption of arsenic by nearly six-fold compared with arsenic exposure alone. The same effect was seen with boscalid, a commonly used pesticide. Also, the researchers exposed lettuce plants to two sizes of polystyrene particles – 20 nanometers and 1,000 nanometers – along with arsenic and boscalid. They found the smaller particles had the biggest impact, increasing arsenic uptake into edible plant tissues nearly threefold compared to plants exposed to arsenic alone.